FDA inspection

Octapharma S.A.S.: FDA inspection ending Dec 6, 2022

FDA inspection 1192276 · Voluntary Action Indicated (VAI) · Lingolsheim

Key facts

Inspection ID 1192276
Firm Octapharma S.A.S.
FEI number 3010600159
Address 72 Rue Du Marechal Foch
City Lingolsheim
Country France
Fiscal year 2023
Inspection end date Dec 6, 2022
Classification Voluntary Action Indicated (VAI)
Project area Blood and Blood Products
Product type Biologics

At a glance

  • None Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections